Filenko, B. M.Starchenko, I. I.Royko, N. V.Vynnyk, N. I.Dyachenko, L. V.Филенко, Борис МиколайовичСтарченко, Іван ІвановичРойко, Наталія ВіталіївнаВинник, Наталія ІванівнаДяченко, Леся ВолодимирівнаФиленко, Борис НиколаевичСтарченко, Иван ИвановичРойко, Наталия ВиталиевнаВинник, Наталия ИвановнаДяченко, Леся Владимировна2020-10-072020-10-072020Clinicomorphological observation of refractory hepatoblastoma: a case report / B. M. Filenko, I. I. Starchenko, N. V. Royko [et al.] // Experimental Oncology. – 2020. – Vol. 42, № 3. – P. 245–247.2312-88521812-9269https://repository.pdmu.edu.ua/handle/123456789/13712The clinical case of refractory hepatoblastoma with lethal outcome followed by pathomorphological verification has been analyzed. The true causes of hepatoblastoma development remain unknown. The prognostic factors of the disease require detailed study in complex investigations that would include histological, clinical, laboratory, and immunohistochemical characteristics. However, comparing clinical and histopathological parameters with CD10 expression could have a diagnostic role and may be useful in understanding tumorigenesis and prognostic analysis of a given tumor.enhepatoblastomaprognostic factorsimmunohistochemical characteristicsCD10Article10.32471/exp-oncology.2312-8852.vol-42-no-3.14855